| Product revenue | 2.33M |
| Other revenue | |
| Revenues, net | 2.33M |
| Cost of goods sold | 1.25M |
| Marketing, general and administrative | 1.16M |
| Research and development | 310.36K |
| Total costs and expenses | 2.72M |
| Loss from operations | -385.28K |
| Equity in Ocular Telehealth Management, LLC | |
| Interest income | 59 |
| Interest expense | -10.31K |
| Total other (expense) and income | -10.25K |
| Net loss from continuing operations before taxes | |
| Provision for income taxes | |
| Net loss from continuing operations | |
| Net income from discontinued operations | |
| Net loss | -395.53K |
| Continuing operations | |
| Discontinued operations | |
| Net loss | -0.05 |
| Continuing operations | |
| Discontinued operations | |
| Net loss | -0.05 |
| Weighted average shares - basic | 7.55M |
| Weighted average shares - diluted | 7.55M |